Liraglutide had no effects on the phosphorylation levels of mTORC1 targets S6K and S6, leading us to futher study the role of AMPK/ACC axis in the regulation of NAFLD. This evidence concerns the gene RPS6KB1 and metabolic dysfunction-associated steatotic liver disease.